US President Donald Trump has announced a 100 per cent tariff on branded and patented pharmaceutical imports from October 1, unless the manufacturer is building a plant on American soil.
Breakdown
- The US President announced a 100% tariff on imported branded and patented pharmaceuticals. 13s
- The tariff applies unless companies manufacture their pharmaceuticals in the US. 25s
- Australia exports nearly $5 billion in pharmaceuticals annually, with the US as the largest market. 43s
- CSL, a major Australian pharmaceutical company, does not expect to be significantly affected due to its US manufacturing footprint. 59s
- The Australian government maintains its commitment to the PBS and says patient costs will not change. 1m 18s
See The Full Story

Global Tariffs
Donald Trump has signed an order to impose tariffs imports into the U.S. from countries including China, Mexico and Canada.